Target intelligence / Profile preview

Multiple cell types and microenvironmental components

Molecular classification
Other
01

Overview

Multiple cell types and microenvironmental components refers to the complex biological ecosystem surrounding a primary tissue or tumor, encompassing diverse cell populations such as immune cells, fibroblasts, and endothelial cells, alongside non-cellular elements like the extracellular matrix (ECM) and various signaling molecules (National Cancer Institute, 2023). This environment, often termed the 'tumor microenvironment' (TME) in oncology, plays a pivotal role in disease pathogenesis by regulating cell proliferation, survival, and migration through biochemical and mechanical cues (Nature Reviews Cancer, 2021). It is not a single molecular target but rather a collection of interacting entities that collectively influence therapeutic outcomes and drug resistance (Cell, 2020). Therapeutic interventions targeting this system often aim to 'reprogram' the environment, such as by inhibiting angiogenesis or depleting immunosuppressive cells, to restore normal tissue homeostasis or enhance the efficacy of primary treatments (Journal of Hematology & Oncology, 2023). Because it encompasses a vast array of distinct biological entities, it is generally classified as a therapeutic context or system rather than a discrete drug target. The complexity of these interactions makes it a significant challenge for drug development, as targeting one component may lead to compensatory mechanisms in another (Cancer Discovery, 2021).

Other names
Tumor microenvironmentTMEStromaCellular microenvironmentTissue microenvironment
02

Mechanism of action

Modulation of the cellular and structural components of the tissue environment to disrupt disease-promoting signaling and improve drug delivery or immune infiltration.

03

Biological functions

Cell-cell communicationExtracellular matrix organizationImmune responseAngiogenesisCell proliferationSignal transduction
04

Disease associations

CancerInflammationFibrosisCardiovascular disease
05

Safety considerations

Immune-related adverse events (irAEs)Systemic toxicity from non-specific modulationImpaired wound healingVascular complicationsComplexity in predicting multi-component interactions
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

PD-L1 expressionTumor-infiltrating lymphocytes (TILs)Cancer-associated fibroblast (CAF) markersExtracellular matrix densityHypoxia-inducible factor 1-alpha (HIF-1α)

Beyond the preview

Go deeper on Multiple cell types and microenvironmental components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cell types and microenvironmental components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call